![Robert Floch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Floch
Algemeen Directeur bij DrugAbuse Pharmaceutical, Inc.
Profiel
Robert Floch is currently the Chief Executive Officer at DrugAbuse Pharmaceutical, Inc. He previously held positions as Director of Research & Development at Rhone Merieux, General Manager-European Operations at SangStat Medical Corp., Principal at Merial SAS, and Vice President-Clinical Development at Effimune SA. He obtained a doctorate degree from the University of Nantes.
Actieve functies van Robert Floch
Bedrijven | Functie | Begin |
---|---|---|
DrugAbuse Pharmaceutical, Inc.
![]() DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Algemeen Directeur | 01-10-2003 |
Eerdere bekende functies van Robert Floch
Bedrijven | Functie | Einde |
---|---|---|
Merial SAS
![]() Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Corporate Officer/Principal | - |
Rhone Merieux
![]() Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Hoofd Techniek/Wetenschap/O&O | - |
Effimune SA
![]() Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Hoofd Techniek/Wetenschap/O&O | - |
SangStat Medical Corp. | Corporate Officer/Principal | - |
Opleiding van Robert Floch
University of Nantes | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
SangStat Medical Corp. | Health Technology |
DrugAbuse Pharmaceutical, Inc.
![]() DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Health Technology |
Rhone Merieux
![]() Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Process Industries |
Merial SAS
![]() Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Health Technology |
Effimune SA
![]() Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Health Technology |